{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:10:35Z","timestamp":1789852235406,"version":"4.0.1"},"reference-count":10,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8,27]]},"DOI":"10.1182\/blood-2015-06-652040","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T16:43:54Z","timestamp":1440693834000},"page":"1052-1053","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["A vaccine against HTLV-1 HBZ makes sense"],"prefix":"10.1182","volume":"126","author":[{"given":"Renaud","family":"Mahieux","sequence":"first","affiliation":[{"name":"EQUIPE LABELIS\u00c9E LIGUE CONTRE LE CANCER, INSERM U1111-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UMR5308"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111721493251600_B1","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-04-641118","article-title":"Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.","author":"Sugata","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2019111721493251600_B2","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111721493251600_B3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma.","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"key":"2019111721493251600_B4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis.","volume":"3","author":"Yamano","year":"2012","journal-title":"Front Microbiol"},{"issue":"5","key":"2019111721493251600_B5","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.","volume":"69","author":"Wattel","year":"1995","journal-title":"J Virol"},{"issue":"5","key":"2019111721493251600_B6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","article-title":"An HTLV-I vaccine: why, how, for whom?","volume":"9","author":"de Th\u00e9","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"2019111721493251600_B7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/aid.1996.12.403","article-title":"Vaccine against human T cell leukemia-lymphoma virus type I: progress and prospects.","volume":"12","author":"Bomford","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"2019111721493251600_B8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/v3071210","article-title":"Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.","volume":"3","author":"Rodr\u00edguez","year":"2011","journal-title":"Viruses"},{"issue":"24","key":"2019111721493251600_B9","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.","volume":"76","author":"Gaudray","year":"2002","journal-title":"J Virol"},{"issue":"9","key":"2019111721493251600_B10","doi-asserted-by":"crossref","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection.","volume":"6","author":"Macnamara","year":"2010","journal-title":"PLoS Pathog"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/9\/1052\/1391251\/1052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/9\/1052\/1391251\/1052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:15:11Z","timestamp":1599498911000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/9\/1052\/126457\/A-vaccine-against-HTLV1-HBZ-makes-sense"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,8,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-06-652040","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}